leisure time -WSS

leisure time

author：Wikipedia 2025-10-01 17:21:31 - browse：5559

Surrounded by tablets, an elder miniature figure walks with a cane next to a stethoscope — coverage from STAT — Adobe

Medicare Advantage is arguably the most controversial health care program right now — a sentiment that was bolstered Friday by striking new data about overpayments and an uncommon political jab during a routine meeting of policy wonks.

The Medicare Payment Advisory Commission, a group that advises Congress on Medicare policy, gathered to discuss its pending March report on the state of Medicare Advantage, the alternative to traditional Medicare that is run by health insurance companies. Medicare Advantage is expected to cost taxpayers $507 billion this year, according to the latest federal estimates.

The group, known as MedPAC, came to several familiar conclusions from the staff’s presentation and report: The federal government significantly overpays Medicare Advantage insurers because they attract healthier, lower-cost people into their plans and then excessively code those people’s health conditions — making Medicare Advantage a drain on taxpayers. MedPAC’s staffers also reiterated that Medicare Advantage’s quality rating system is “not a good basis for judging quality,” and therefore leads to further overpayments because insurers are paid bonuses based on this quality system.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： It's time to retire 'poor historian' from clinicians' vocabularies

explore

focus

WSS

Second House panel advances two

Positive childhood experiences can help future health

Readers respond to H5N1 and livestock movements, and more

Arc Institute generative AI designs new CRISPR systems

Second House panel advances two

Asbestos, a deadly carcinogen, banned by EPA

entertainment

leisure time

hotspot

Moonlake's readout produced a cash windfall. Risks remain

Stop the failed accountable care organization experiment

Moonlake's readout produced a cash windfall. Risks remain

When prostate cancer spreads, where it goes matters

Guidelines to prevent youth baseball injuries need more muscle

Intermittent fasting comes with a heart risk? Not so fast

Trump demands the U.S. pay no more for drugs than other countries … again

Creating egg and sperm cells from stem cells raises ethical issues

Jerome Adams on the need for new antivirals for Covid

Physicians and social media: If you see something, say something?

leisure time

Cytokinetics CEO stresses company can launch heart drug on its own

Asbestos, a deadly carcinogen, banned by EPA

Health AI adoption puts security, privacy startups on investors' radar

Readout LOUD podcast: Live from STAT Breakthrough Summit West

With measles on the rise, a personal story of a devastating disease

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

explore

explore

focus

hotspot